ABSTRACT Objective: The US Public Health Service Panel on Cost‐Effectiveness has
recommended the use of quality‐adjusted life‐years (QALYs) as the best way to estimate …

Purpose: This paper investigates the impact of quality‐of‐life adjustment on cost‐
effectiveness analyses, by comparing ratios from published studies that have reported both …

PURPOSE: Cost-utility analyses (CUAs) present the value of an intervention as the ratio of
its incremental cost divided by its incremental survival benefit, with survival weighted by …

▪ Abstract Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of
obtaining an additional unit of health outcome, can help decision makers achieve more …

New cancer treatments pose a substantial financial burden on health-care systems, insurers,
patients, and society. Cost–utility analyses (CUAs) of cancer-related interventions have …

The goals of cancer treatment and cancer prevention are to extend life expectancy and to
improve quality of life in the years prior to death. Typically, outcomes of cancer treatment are …

Context Substantial innovation related to cancer prevention and treatment has occurred in
recent decades. However, these innovations have often come at a significant cost. Cost …

Outcomes research is the study of the net effects of the health care process on the health
and well-being of individuals and populations. It encompasses a wide breadth of issues …

Medical cost-effectiveness analyses may be conducted from numerous perspectives, almost
all of which naturally involve consequences that extend into the future. The most widely …

While the past decade has seen the development of multiple new interventions to diagnose
and treat cancer, as well as to improve the quality of life for cancer patients, many of these …